|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BIOJECT MEDICAL TECHNOLOGIES INC, 10-Q, EX-10, 2000-11-13 |
Next: MARITRANS INC /DE/, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 4,470,288
<SECURITIES> 11,839,067
<RECEIVABLES> 388,033
<ALLOWANCES> 20,871
<INVENTORY> 745,333
<CURRENT-ASSETS> 15,063,957
<PP&E> 4,731,952
<DEPRECIATION> 3,589,228
<TOTAL-ASSETS> 19,310,685
<CURRENT-LIABILITIES> 1,244,417
<BONDS> 0
0
15,268,469
<COMMON> 66,381,232
<OTHER-SE> (63,583,433)
<TOTAL-LIABILITY-AND-EQUITY> 19,310,685
<SALES> 637,319
<TOTAL-REVENUES> 1,014,309
<CGS> 1,156,728
<TOTAL-COSTS> 3,380,396
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (1,962,990)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,525,926)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,525,926)
<EPS-BASIC> (0.37)
<EPS-DILUTED> (0.37)
</TABLE>
|
|